TriSalus Life Sciences
TLSI
TLSI
72 hedge funds and large institutions have $206M invested in TriSalus Life Sciences in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $219M → $206M (-$12.4M)
Holders
72
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.89M | |
| 2 | +$5.97M | |
| 3 | +$4.23M | |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$2.04M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.02M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$7.66M | |
| 3 | -$6.69M | |
| 4 |
Millennium Management
New York
|
-$1.41M |
| 5 |
KC
Kryger Capital
London,
United Kingdom
|
-$552K |